Ambient

Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1) is a protein that in humans is encoded by the CD274 gene. The formation of the PD-1 receptor / PD-L1 or B7.1 receptor /PD-L1 ligand complex transmits an inhibitory signal which reduces the proliferation of these CD8+ T cells at the lymph nodes. PD-1 is also able to control the accumulation of foreign antigen specific T cells in the lymph nodes through apoptosis, which is further mediated by a lower regulation of the gene Bcl-2.

The thromboxane A2 (TxA2) receptor (TP) is a member of the G protein-coupled receptor (GPCR) superfamily which mediates TxA2-induced platelet aggregation and vasoconstriction. Dysregulation of TxA2 synthesis and function has been implicated in the pathogenesis of a number of disease states including myocardial ischemia, asthma, pregnancy-induced hypertension, and a variety of kidney diseases. TP receptors (Thromboxane A2 receptors) are widely distributed among different organ systems and localized on both cell membranes and in intracellular structures. Two isoforms of human TPs have been cloned from placenta (TPα) and endothelium (TPβ) that differ in their mechanisms and kinetics of desensitization and internalization. The TPs are linked via the Gq/G11 class of G proteins to phospholipase C (PLC), which hydrolyzes phosphoinositides to two potent second messengers: inositol 1,4,5-trisphosphate, which leads to an increase in cytoplasmic free calcium, and diacylglycerol (DAG), which activates protein kinase C (PKC).

Recombinant HEK293T cells stably overexpress human SARS-CoV-2 spike protein on their surface. The surface expression of SARS-CoV-2 spike protein is validated by FACS analysis. This stable cell line product is designed for screening antibodies against SARS-CoV-2 spike protein, as well as for measuring binding affinity and stability of antibody based biologics that bind with spike protein. GenScript also offers spike protein expressing CHO-K1 stable cell line (Cat. No. M00803) for SARS-CoV-2 study.

Hematin

Hematin

Hematin

Hematoporphyrin

Hematoporphyrin

Hematoporphyrin

Hematoporphyrin

Hematoxylin

Hematoxylin

Hematoxylin

Hematoxylin

Hematoxylin

Hematoxylin, Hydrate

Hematoxylin, Hydrate

Glycated hemoglobin (HbA1c) is formed by hemoglobin’s exposure to plasma glucose in a non-enzymatic process. As the average amount of plasma glucose increases, the fraction of HbA1c scales up. HbA1c reflects average plasma glucose over the previous eight to twelve weeks and it can be used as a marker to measure long-term blood glucose levels. HbA1c test is routinely performed in people with type 1 and type 2 diabetes to evaluate how well diabetes is controlled. The normal range for HbA1c level is less than 6%.

Glycated hemoglobin (HbA1c) is formed by hemoglobin’s exposure to plasma glucose in a non-enzymatic process. As the average amount of plasma glucose increases, the fraction of HbA1c scales up. HbA1c reflects average plasma glucose over the previous eight to twelve weeks and it can be used as a marker to measure long-term blood glucose levels. HbA1c test is routinely performed in people with type 1 and type 2 diabetes to evaluate how well diabetes is controlled. The normal range for HbA1c level is less than 6%.

Glycated hemoglobin (HbA1c) is formed by hemoglobin’s exposure to plasma glucose in a non-enzymatic process. As the average amount of plasma glucose increases, the fraction of HbA1c scales up. HbA1c reflects average plasma glucose over the previous eight to twelve weeks and it can be used as a marker to measure long-term blood glucose levels. HbA1c test is routinely performed in people with type 1 and type 2 diabetes to evaluate how well diabetes is controlled. The normal range for HbA1c level is less than 6%.

Hemoglobin, Bovine, Powder

Hemoglobin, Bovine, Powder

Hemoglobin, Bovine, Powder

HEPES Sodium Salt